Briacell Therapeutics Corp (BCT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 72 | 4 | 4 | 4 | 4 |
| Accounts receivable | -736 | 15 | -9 | -3 | -4 |
| Accounts payable and accrued liabilities | 748 | 2,711 | 3,278 | -690 | 128 |
| Other Working Capital | 1,294 | 3,737 | 1,843 | 180 | -3,946 |
| Other Operating Activity | -5,414 | -11,550 | -12,516 | -7,097 | -7,101 |
| Operating Cash Flow | $-4,036 | $-5,084 | $-7,401 | $-7,605 | $-10,919 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 0 | -225 | N/A | N/A | N/A |
| Other Investing Activity | -457 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-457 | $-225 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 4,419 | 0 | 0 | 0 | 4,000 |
| Financing Cash Flow | $4,419 | $0 | $0 | $0 | $4,000 |
| Beginning Cash Position | 936 | 6,245 | 13,646 | 21,251 | 28,170 |
| End Cash Position | 862 | 936 | 6,245 | 13,646 | 21,251 |
| Net Cash Flow | $-74 | $-5,309 | $-7,401 | $-7,605 | $-6,919 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,036 | -5,084 | -7,401 | -7,605 | -10,919 |
| Free Cash Flow | -4,036 | -5,084 | -7,401 | -7,605 | -10,919 |